HOME / PUBLICATIONS /

Additive prognostic value of interleukin 6 measured at peak phase of dobutamine stress echo in patients with coronary artery disease. A six-year follow-up study

Citation:

Ikonomidis I, Athanassopoulos G, Stamatelopoulos K, Revela I, Lekakis J, Marinou M, Venetsanou K, Kremastinos D, Cokkinos D, Nihoyannopoulos P. Additive prognostic value of interleukin 6 measured at peak phase of dobutamine stress echo in patients with coronary artery disease. A six-year follow-up study. In: EUROPEAN HEART JOURNAL. Vol. 28. OXFORD UNIV PRESS GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND; 2007. pp. 277–277.